CHI Releases Conference Proceedings from its Ninth Annual High-Content Analysis Event

Copies of the speakers slides and poster abstracts are available on CD for those that missed this conference that took place on January 10-13, 2012.
 
Feb. 22, 2012 - PRLog -- Last month, more than 350 delegates from Pharma, Biotechnology and Academia came together in San Francisco to discuss applications and technologies in the field of High-Content Analysis (HCA) and Screening. The event featured User group meetings and an advanced short course. For a limited time, those that did not attend this event can obtain a copy of the conference proceedings on CD featuring all the information our delegates received on-site from our speakers. This year featured participants from 21 different countries, representing 182 different organizations with more than 20% of the attendance from Pharmaceutical companies. The event also featured a good networking blend of Scientists (60%) and Executives (20%). More than 40% of the participants were decision makers.

CD CONTENTS:

55+ Speaker presentations
40+ Posters
Speaker Contact Information
Sponsors, Exhibitors & Media Partners Information

COVERAGE:

HCA for Toxicity Assessment and Drug Screening
High-Content Image Analysis and Data Management
HCA for Pathway Analysis and RNAi
HCA of Stem Cells, Tissues, and Whole Organisms
3-D Cell Models
Neuronal Imaging
High-Content Flow Cytometry
Novel Probes and Biosensors
High-Content Screening of Live Cells
FLIM-FRET
Miniaturization Approaches

Order CD online for $500: http://www.highcontentanalysis.com or call 781-972-5400.

About Cambridge Healthtech Institute (http://www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com
End
Cambridge Healthtech Institute PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share